Search
for
Sort by
Research 61–90 of 1000+
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Sublingual tofacitinib for alopecia areata: a roll‐over pilot clinical trial and analysis of pharmacokinetics
- The genetically programmed hair growth cycle and alopecia: what is there to know?
- Long-term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-year Results from the ALLEGRO-LT Phase 3, Open-label Study
- Cicatricial Alopecia
- Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial
- Coexistence of alopecia areata and fixed drug eruption: An uncommon isotopic phenomenon?
- A Novel Hope for Alopecia Totalis Patients: Case Report
- Alopecias
- Acquired scalp alopecia. Part II: A review
- Primary cicatricial alopecias
- Down-RANKing the Threat of HSV-1: RANKL Upregulates MHC-Class-I-Restricted Anti-Viral Immunity in Herpes Simplex Virus Infection
- Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study
- New drugs under investigation for the treatment of alopecias
- Utility of azathioprine, methotrexate and cyclosporine as steroid‐sparing agents in chronic alopecia areata: a retrospective study of continuation rates in 138 patients
- Differential diagnosis of alopetia in children and adolescents
- New therapies for alopecia areata
- Ritlecitinib in severe alopecia areata: a profile of its use
- ORAL TOFACITINIB IN MODERATE AND SEVERE ALOPECIA AREATA: CASE SERIES OF 14 PATIENTS
- Epidemiology and burden of alopecia areata in Taiwan: a systematic review
- Current and future pharmacotherapy for alopecia areata
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- Epidemiology, management and the associated burden of mental health illness, atopic and autoimmune conditions, and common infections in alopecia areata: protocol for an observational study series
- Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article